BPC-157 + TB 500 Wolverine Peptide Injections Newport Beach
Physician-guided BPC-157 + TB 500 Wolverine Peptide Therapy consultations with Dr. Rob Berberian, serving Newport Beach, Orange County, and patients across California. Every plan is custom tailored to your current health and goals.
BPC-157 + TB 500 Wolverine Peptide Therapy in Newport Beach, Orange County
BPC-157 + TB 500 Wolverine Stack Peptide Therapy pairs two synthetic peptides that researchers have studied for tissue repair. The “Wolverine” label is a nickname borrowed from the comic-book character known for fast healing. It is a marketing term, not a clinical promise. At his Newport Beach office, Dr. Rob Berberian offers a consultation to decide whether BPC-157 + TB 500 Wolverine Peptide Injections are appropriate for you, with patients visiting from Newport Beach, Orange County, and throughout California.
BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide derived from a protein found in gastric juice. In laboratory and animal studies it has been associated with faster healing of tendon, ligament, muscle, and gut tissue and with new blood vessel formation (Sikiric et al., 2011; Chang et al., 2011; Seiwerth et al., 2014). TB-500 is a synthetic fragment related to thymosin beta-4, a naturally occurring peptide involved in cell migration, wound repair, and angiogenesis (Goldstein et al., 2012).
Important, please read: Neither BPC-157 nor TB-500 is approved by the U.S. Food and Drug Administration for any medical use. Most of the supporting evidence comes from cell and animal research, and published human data are limited to small, short studies (Lee & Padgett, 2021; Vasireddi et al., 2025). In July 2026 the FDA’s Pharmacy Compounding Advisory Committee voted to recommend both substances for the 503A bulks list, but that recommendation is advisory and is not a final FDA decision or an approval. Your consultation will cover exactly what is and is not known.
What BPC-157 + TB 500 Is Used For
Patients in Newport Beach and Orange County most often ask about this combination in connection with soft-tissue and recovery goals. The list below describes the areas where the research and clinical interest are concentrated. It is not a list of approved treatments, and results are not guaranteed.
- Tendon and ligament injuries. Rat studies show faster tendon outgrowth, cell survival, and cell migration with BPC-157 (Staresinic et al., 2003; Chang et al., 2011; Gwyer et al., 2019).
- Muscle and joint discomfort. A retrospective study of 12 patients reported symptom improvement after BPC-157 knee injections. It was small and uncontrolled (Lee & Padgett, 2021).
- Post-exercise and post-injury recovery. Common patient goal. Direct human evidence for the combination is lacking.
- Gut and inflammatory conditions. BPC-157 was originally studied for gastrointestinal healing (Sikiric et al., 2011). The FDA committee reviewed BPC-157 specifically for ulcerative colitis and TB-500 for wound healing.
- Wound healing and circulation. Thymosin beta-4 has been studied for wound repair and angiogenesis (Philp et al., 2004; Goldstein et al., 2012).
Dr. Rob Berberian will review your history and goals and explain which of these, if any, fit your situation.
Advantages and Disadvantages of BPC-157 + TB 500 Wolverine Peptide Therapy
Potential advantages
- Strong signals of tissue repair in animal and laboratory models
- Small, subcutaneous injections rather than surgery
- Short sessions with no general anesthesia
- Plan adjusted to your health, activity level, and goals
- Physician-supervised, with a candidacy screening first
Potential disadvantages
- No FDA approval; limited high-quality human trials
- Long-term safety in people is not established
- Product quality depends on the compounding source
- Results vary and cannot be guaranteed
- Both peptides are banned for tested athletes by WADA (class S0)
- Insurance generally does not cover it
Risks, Benefits, and Regulatory Status in California
Possible benefits
Animal studies suggest support for tendon, muscle, ligament, and blood-vessel repair. Some patients report feeling less sore and recovering faster. Those reports are anecdotal and may reflect rest, rehabilitation, or the placebo effect as much as the peptide.
Possible risks and side effects
- Injection-site redness, swelling, bruising, or irritation
- Headache, nausea, dizziness, or flushing reported anecdotally
- Allergic reaction or immune response; the FDA has flagged immunogenicity as a concern for some peptides
- Impurities or dosing inconsistency if a product is not produced under pharmacy-grade standards
- Theoretical concern about promoting blood-vessel growth in people with a history of cancer, which is why a cancer history is reviewed at consultation
- Unknown long-term effects, and unknown effects during pregnancy or breastfeeding
Where the rules stand
BPC-157 and TB-500 are not FDA-approved drugs. Both were removed from the FDA’s Category 2 safety-risk list in 2026 after their nominations were withdrawn, and on July 23, 2026 an FDA advisory committee voted 8 to 6 (with one abstention) in favor of adding each to the 503A bulks list. The FDA still has to complete rulemaking, so this is a developing area. Dr. Rob Berberian’s office will explain current sourcing and legal status at your visit.
Who may not be a candidate: people who are pregnant or nursing, have an active or past cancer, or compete in drug-tested sport. The consultation determines candidacy.
What to Expect: Your Visit and How You May Feel
- Consultation in Newport Beach. Dr. Rob Berberian reviews your medical history, medications, injuries, and goals, and explains the evidence, the risks, and your alternatives.
- Candidacy decision. If peptide therapy is appropriate, you receive a custom tailored plan. If it is not, you will be told why.
- Injections. Peptides are given as small subcutaneous injections. Most people describe a brief pinch.
- Afterward. Mild soreness or redness at the site is the most common experience. Many people feel nothing noticeable right away. Any change in recovery, if it occurs, tends to be gradual.
- Follow-up. Your response is reviewed and the plan is adjusted or stopped as needed.
Call your doctor promptly for hives, facial swelling, trouble breathing, a spreading rash, or worsening pain.
Consultation Fee and Cost of BPC-157 + TB 500 Wolverine Peptide Therapy
| Service | Price |
|---|---|
| Consultation to determine candidacy | $250 |
| BPC-157 + TB 500 Wolverine Peptide Therapy | $500 |
A consultation is required to determine whether you are a proper candidate. Each patient receives a custom tailored treatment based on current health and the goals desired.
BPC-157 + TB 500 Wolverine Peptide Injections Across Orange County and California
Dr. Rob Berberian’s office is in Fashion Island’s Newport Center, convenient to Newport Beach, Corona del Mar, Newport Coast, Costa Mesa, Irvine, Laguna Beach, Huntington Beach, Tustin, Mission Viejo, Dana Point, San Clemente, and surrounding Orange County cities. Patients also travel from Los Angeles, San Diego, and elsewhere in California for BPC-157 + TB 500 Wolverine Peptide Therapy consultations.
Office: 200 Newport Center Dr, Suite 202, Newport Beach, CA 92660 · Phone: 424-744-3816
BPC-157 + TB 500 Questions in Newport Beach
What is BPC-157 + TB 500 Wolverine Peptide Therapy?
It is the nickname for combining BPC-157 and TB-500, two peptides studied for tissue repair. Evidence is largely preclinical, and neither is FDA-approved.
How much does BPC-157 + TB 500 Wolverine Peptide Therapy cost in Newport Beach?
Therapy is $500 after a $250 consultation. Plans are custom tailored.
Is BPC-157 + TB 500 safe?
Short-term side effects reported are generally mild, but long-term human safety data are lacking. Your consultation covers your individual risk.
Will I feel it working?
Effects, if any, are usually gradual and vary by person. Results are not guaranteed.
Does insurance cover peptide injections?
Generally no, because these peptides are not FDA-approved.
Will it show up on an athletic drug test?
Both are prohibited at all times under the WADA Prohibited List (S0). Tested athletes should not use them.
More Services from Dr. Rob Berberian in Newport Beach
Follistatin Injections
Sermorelin Injections
Epithalon Injections
NAD+ Injections
IV Exosome Therapy
Dr. Rob Berberian offers IV Exosome Therapy in Newport Beach for Orange County and California patients interested in regenerative wellness options. Ask about it at your consultation.
Exosome Hair Injections
Thinning hair? Exosome Hair Injections in Newport Beach are designed to support healthier-looking hair growth in the scalp.
FUE Hair Transplant
For permanent results, Dr. Rob Berberian performs FUE Hair Transplant in Newport Beach for patients across Orange County. Celebrities and executives can choose the VIP FUE Hair Transplant, an option that does not involve shaving the hair.
Find Out If BPC-157 + TB 500 Is Right for You
Schedule a $250 consultation with Dr. Rob Berberian in Newport Beach to learn whether you are a candidate for a custom tailored plan.
References
- Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-1632.
- Seiwerth S, Brcic L, Vuletic LB, et al. BPC 157 and blood vessels. Curr Pharm Des. 2014;20(7):1121-1125.
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-780.
- Staresinic M, Petrovic I, Novinscak T, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-983.
- Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153-159.
- Lee E, Padgett B. Intra-articular injection of BPC 157 for multiple types of knee pain. Altern Ther Health Med. 2021;27(4):8-13.
- Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS J. 2025.
- Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37-51.
- Philp D, Nguyen M, Scheremeta B, et al. Thymosin β4 increases hair growth by activation of hair follicle stem cells. FASEB J. 2004;18(2):385-387.
- Ruff D, Crockford D, Girardi G, Zhang Y. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin β4 in healthy volunteers. Ann N Y Acad Sci. 2010;1194:223-229.
- U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee meeting, July 23-24, 2026: briefing materials on BPC-157- and TB-500-related bulk drug substances. FDA.gov. July 2026.
- U.S. Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. FDA.gov. Updated 2026.
- World Anti-Doping Agency. The 2026 Prohibited List, Section S0: Non-Approved Substances. WADA; January 2026.
Dr. Rob Berberian - Cosmetic Medicine · 200 Newport Center Dr, Suite 202, Newport Beach, CA 92660 · 424-744-3816
Disclaimer: This page is for general information and is not medical advice. BPC-157 and TB-500 are not FDA-approved. Individual results vary and are not guaranteed. A consultation is required to determine candidacy. Do not use if pregnant or nursing, or if you have a history of cancer, without physician clearance.
